SEC Company Response from Dare Bioscience, Inc. (DARE) (CIK 0001401914) (DARE) — May 8, 2020
Dare Bioscience, Inc. (DARE) (CIK 0001401914)
Date: May 8, 2020 · CIK: 0001401914 · Accession: 0001401914-20-000062
AI Filing Summary & Sentiment
File numbers found in text: 333-237954
Letter
Re:
Document
May 8, 2020
Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Tim Buchmiller
Daré Bioscience, Inc. Registration Statement on Form S-1 (File No. 333-237954)
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Daré Bioscience, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced registration statement to 4:00 p.m., Eastern Standard Time, on Tuesday, May 12, 2020, or as soon thereafter as practicable.
Daré Bioscience, Inc.
/s/ Lisa Walters-Hoffert
Lisa Walters-Hoffert
Chief Financial Officer
Show Raw Text
CORRESP 1 filename1.htm Document May 8, 2020 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Tim Buchmiller Re: Daré Bioscience, Inc. Registration Statement on Form S-1 (File No. 333-237954) Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Daré Bioscience, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced registration statement to 4:00 p.m., Eastern Standard Time, on Tuesday, May 12, 2020, or as soon thereafter as practicable. Daré Bioscience, Inc. /s/ Lisa Walters-Hoffert Lisa Walters-Hoffert Chief Financial Officer